The British Journal of Cardiology is indexed on Pub Med Central®
This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: treatment

October 2011 Br J Cardiol 2011;18:219–22 doi:10.5837/bjc.2011.002

Patent foramen ovale: diagnosis, indications for closure and complications

Sudhakar George, David Hildick-Smith 

Abstract

(more…)

| Full text

January 2009 Br J Cardiol 2009;16:36-41

Amyloid heart disease

Simon Dubrey

Abstract

(more…)

| Full text

January 2008 Br J Cardiol 2008;15:48-50

Pharmacological secondary prevention in people with peripheral arterial disease compared to thosewith coronary artery disease: a missed opportunity

Simon EJ Janes, Joe West, Brian R Hopkinson, John T Walsh

Abstract

Introduction Patients with peripheral arterial disease (PAD) have a high prevalence of modifiable risk factors for coronary artery disease (CAD).1 Consequently, they represent a suitable target for secondary prevention and there is strong evidence that this is beneficial.2–4 We aimed to establish whether people with PAD who are admitted to hospital receive equal pharmacological secondary prevention to those with CAD. Methods We prospectively recruited patients from 1st March 2003 until 1st June 2003 admitted to a vascular surgery ward (PAD) or cardiology ward (CAD) until discharge. All patients had symptomatic established disease and underw

| Full text

November 2005 Br J Cardiol 2005;12:456-8

How would British stroke physicians diagnose and treat hypoxia in patients with acute stroke?

Christine Roffe, Amit Arora, Peter Crome, Richard Gray

Abstract

No content available

| Full text

September 2003 Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 82–AIC 88

Atrial fibrillation after coronary bypass surgery – pathophysiology, resource utilisation and management strategies

Joseph Alex, Gurpreet S Bhamra, Alex RJ Cale, Steven C Griffin, Michael E Cowen, Levent Guvendik

Abstract

No content available

| Full text

July 2003 Br J Cardiol 2003;10:297-304

Clinical usefulness of HDL cholesterol as a target to lower risk of coronary heart disease – Summary of evidence and recommendations of an expert group*

Frank M Sacks

Abstract

No content available

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now